{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:38:51Z","timestamp":1781080731956,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:00:00Z","timestamp":1625184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:00:00Z","timestamp":1625184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100011775","name":"BC Children\u2019s Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000233","name":"Genome BC","doi-asserted-by":"crossref","award":["SOF-195"],"award-info":[{"award-number":["SOF-195"]}],"id":[{"id":"10.13039\/501100000233","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012280","name":"Rare Diseases Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012280","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["301221"],"award-info":[{"award-number":["301221"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008762","name":"Genome Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008762","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CIHR New Investigator Award"},{"name":"CFRI Fellowship to AM"},{"name":"Alberta Children\u2019s Hospital Research Institute Foundation D\u00edaz"},{"DOI":"10.13039\/501100000233","name":"Genome BC","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000233","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s10048-021-00652-7","type":"journal-article","created":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T05:02:34Z","timestamp":1625202154000},"page":"251-262","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Secondary biogenic amine deficiencies: genetic etiology, therapeutic interventions, and clinical effects"],"prefix":"10.1007","volume":"22","author":[{"given":"Clara D.","family":"van Karnebeek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Blydt-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison M.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Avramovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britt","family":"Drogemoller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casper","family":"Shyr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Mwenifumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Ghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Stockler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan M.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"CAUSES Genomic Study","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin J.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wyeth W.","family":"Wasserman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4472-8584","authenticated-orcid":false,"given":"Maja","family":"Tarailo-Graovac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella A.","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,2]]},"reference":[{"key":"652_CR1","unstructured":"Purves D, Augustine GJ, Fitzpatrick D, et al (2001) Neuroscience. 2nd edition. Sunderland (MA): Sinauer Associates; 2001. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK10799\/"},{"key":"652_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2015.172","author":"J Ng","year":"2015","unstructured":"Ng J, Papandreou A, Heales SJ, Kurian MA (2015) Monoamine neurotransmitter disorders - clinical advances and future perspectives. Nat Rev Neurol. https:\/\/doi.org\/10.1038\/nrneurol.2015.172","journal-title":"Nat Rev Neurol"},{"key":"652_CR3","doi-asserted-by":"publisher","unstructured":"Mercimek-Mahmutoglu S, Sidky S, Hyland K, Patel J, Donner J, Logan W, Mendoza-Londono R, et al (2015) Prevalence of inherited neurotransmitter disorders in patients with movement disorders and epilepsy: a retrospective cohort study. Orphanet Rare Dis 10(1). https:\/\/doi.org\/10.1186\/s13023-015-0234-9","DOI":"10.1186\/s13023-015-0234-9"},{"issue":"6","key":"652_CR4","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s10545-010-9200-9","volume":"33","author":"E De Grandis","year":"2010","unstructured":"De Grandis E, Serrano M, P\u00e9rez-Due\u00f1as B, Ormaz\u00e1bal A, Montero R, Veneselli E, Pineda M et al (2010) Cerebrospinal fluid alterations of the serotonin product, 5-hydroxyindolacetic acid, in neurological disorders. J Inherit Metab Dis 33(6):803\u2013809. https:\/\/doi.org\/10.1007\/s10545-010-9200-9","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"652_CR5","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/dmcn.12116","volume":"55","author":"M Molero-Luis","year":"2013","unstructured":"Molero-Luis M, Serrano M, Ormaz\u00e1bal A, P\u00e9rez-Due\u00f1as B, Garc\u00eda-Cazorla \u00c0, Pons R, Artuch R (2013) Homovanillic acid in cerebrospinal fluid of 1388 children with neurological disorders. Dev Med Child Neurol 55(6):559\u2013566. https:\/\/doi.org\/10.1111\/dmcn.12116","journal-title":"Dev Med Child Neurol"},{"issue":"7","key":"652_CR6","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1038\/s41436-018-0376-y","volume":"21","author":"AM Matthews","year":"2019","unstructured":"Matthews AM, Blydt-Hansen I, Al-Jabri B, Andersen J, Tarailo-Graovac M, Price M, Selby K et al (2019) Atypical cerebral palsy: genomics analysis enables precision medicine. Genet Med 21(7):1621\u20131628. https:\/\/doi.org\/10.1038\/s41436-018-0376-y","journal-title":"Genet Med"},{"issue":"1","key":"652_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S1090-3798(02)00137-X","volume":"7","author":"JC Van Der Heyden","year":"2003","unstructured":"Van Der Heyden JC, Rotteveel JJ, Wevers RA (2003) Decreased homovanillic acid concentrations in cerebrospinal fluid in children without a known defect in dopamine metabolism. Eur J Paediatr Neurol 7(1):31\u201337. https:\/\/doi.org\/10.1016\/S1090-3798(02)00137-X","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"652_CR8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1528-1157.1992.tb02315.x","volume":"33","author":"O Devinsky","year":"1992","unstructured":"Devinsky O, Emoto S, Goldstein DS, Stull R, Porter RJ, Theodore WH, Suzan Nadi N (1992) Cerebrospinal fluid and serum levels of DOPA, catechols, and monoamine metabolites in patients with epilepsy. Epilepsia 33(2):263\u2013270. https:\/\/doi.org\/10.1111\/j.1528-1157.1992.tb02315.x","journal-title":"Epilepsia"},{"issue":"10","key":"652_CR9","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/j.1469-8749.2007.00740.x","volume":"49","author":"A Garc\u00eda-Cazorla","year":"2007","unstructured":"Garc\u00eda-Cazorla A, Serrano M, P\u00e9rez-Due\u00f1as B, Gonz\u00e1lez V, Ormaz\u00e1bal A, Pineda M, Fern\u00e1ndez-\u00e1lvarez E, Campistol JMD, Artuch RMD (2007) Secondary abnormalities of neurotransmitters in infants with neurological disorders. Dev Med Child Neurol 49(10):740\u2013744. https:\/\/doi.org\/10.1111\/j.1469-8749.2007.00740.x","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"652_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1006\/mgme.2001.3187","volume":"73","author":"V Ramaekers","year":"2001","unstructured":"Ramaekers V, Th J, Senderek M, H\u00e4usler M, H\u00e4ring N, Abeling K, Zerres C, Bergmann GH, Blau N (2001) A novel neurodevelopmental syndrome responsive to 5-hydroxytryptophan and carbidopa. Mol Genet Metab 73(2):179\u2013187. https:\/\/doi.org\/10.1006\/mgme.2001.3187","journal-title":"Mol Genet Metab"},{"issue":"1","key":"652_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ymgme.2015.11.008","volume":"117","author":"GA Horvath","year":"2016","unstructured":"Horvath GA, Demos M, Shyr C, Matthews A, Zhang L, Race S, Stockler-Ipsiroglu S et al (2016) Secondary neurotransmitter deficiencies in epilepsy caused by voltage-gated sodium channelopathies: a potential treatment target? Mol Genet Metab 117(1):42\u201348. https:\/\/doi.org\/10.1016\/j.ymgme.2015.11.008","journal-title":"Mol Genet Metab"},{"issue":"23","key":"652_CR12","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1056\/NEJMoa1515792","volume":"374","author":"M Tarailo-Graovac","year":"2016","unstructured":"Tarailo-Graovac M, Shyr C, Ross CJ, Horvath GA, Salvarinova R, Ye XC, Zhang L-H et al (2016) Exome sequencing and the management of neurometabolic disorders. N Engl J Med 374(23):2246\u20132255. https:\/\/doi.org\/10.1056\/NEJMoa1515792","journal-title":"N Engl J Med"},{"key":"652_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2014.01.011","author":"CDM Van Karnebeek","year":"2014","unstructured":"Van Karnebeek CDM, Shevell M, Zschocke J, Moeschler JB, Stockler S (2014) The metabolic evaluation of the child with an intellectual developmental disorder: diagnostic algorithm for identification of treatable causes and new digital resource. Mol Genet Metab. https:\/\/doi.org\/10.1016\/j.ymgme.2014.01.011","journal-title":"Mol Genet Metab"},{"issue":"S6","key":"652_CR14","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1002\/ana.10627","volume":"54","author":"K Hyland","year":"2003","unstructured":"Hyland K (2003) The lumbar puncture for diagnosis of pediatric neurotransmitter diseases. Ann Neurol 54(S6):S13-17. https:\/\/doi.org\/10.1002\/ana.10627","journal-title":"Ann Neurol"},{"issue":"1","key":"652_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ajhg.2017.05.016","volume":"101","author":"A Lehman","year":"2017","unstructured":"Lehman A, Thouta S, Mancini G, Naidu S, VanSlegtenhorst M, McWalter K et al (2017) Loss-of-Function and gain-of-function mutations in KCNQ5 cause intellectual disability or epileptic encephalopathy. Am J Hum Genet 101(1):65\u201374","journal-title":"Am J Hum Genet"},{"issue":"1","key":"652_CR16","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1177\/0883073817740443","volume":"33","author":"GA Horvath","year":"2018","unstructured":"Horvath GA, Tarailo-Graovac M, Bartel T, Race S, Van Allen MI, Blydt-Hansen I, Ross CJ, Wasserman WW, Connolly MB, van Karnebeek CDM (2018) Improvement of self-injury with dopamine and serotonin replacement therapy in a patient with a hemizygous PAK3 mutation: a new therapeutic strategy for neuropsychiatric features of an intellectual disability syndrome. J Child Neurol 33(1):106\u2013113. https:\/\/doi.org\/10.1177\/0883073817740443","journal-title":"J Child Neurol"},{"key":"652_CR17","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.neuroscience.2018.05.031","volume":"384","author":"G Horvath","year":"2018","unstructured":"Horvath G, Zhao Y, Tarailo-Graovac M, Boelman C, Gill H, Shyr C, Lee J, Blydt-Hansen I, Drogemoller B, Moreland J, Ross C, Wasserman W, Masotti A, Slesinger P, van Karnebeek C (2018) Gain-of-function KCNJ6 mutation in a severe hyperkinetic movement disorder phenotype. Neuroscience 384:152\u2013164. https:\/\/doi.org\/10.1016\/j.neuroscience.2018.05.031","journal-title":"Neuroscience"},{"issue":"9","key":"652_CR18","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/nn.4352","volume":"19","author":"SH Lelieveld","year":"2016","unstructured":"Lelieveld SH, Reijnders MRF, Pfundt R, Yntema HG, Kamsteeg EJ, De Vries P, De Vries BBA et al (2016) Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability. Nat Neurosci 19(9):1194\u20131196. https:\/\/doi.org\/10.1038\/nn.4352","journal-title":"Nat Neurosci"},{"issue":"1","key":"652_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep27491","volume":"6","author":"J Xing","year":"2016","unstructured":"Xing J, Kimura H, Wang C, Ishizuka K, Kushima I, Arioka Y, Yoshimi A et al (2016) Resequencing and association analysis of six PSD-95-related genes as possible susceptibility genes for schizophrenia and autism spectrum disorders. Sci Rep 6(1):1\u20138. https:\/\/doi.org\/10.1038\/srep27491","journal-title":"Sci Rep"},{"key":"652_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomic and the Association for Molecular Pathology. Genet Med 17:405\u2013423","journal-title":"Genet Med"},{"issue":"4","key":"652_CR21","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s10545-014-9697-4","volume":"37","author":"C Marecos","year":"2014","unstructured":"Marecos C, Ng J, Kurian MA (2014) What is new for monoamine neurotransmitter disorders? J Inherit Metab Dis 37(4):619\u201326. https:\/\/doi.org\/10.1007\/s10545-014-9697-4","journal-title":"J Inherit Metab Dis"},{"issue":"8","key":"652_CR22","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S1474-4422(11)70141-7","volume":"10","author":"MA Kurian","year":"2011","unstructured":"Kurian MA, Gissen P, Smith M, Heales SJr, Clayton PT (2011) The monoamine neurotransmitter disorders: an expanding range of neurological syndromes. The Lancet 10(8):721\u2013733","journal-title":"The Lancet"},{"key":"652_CR23","doi-asserted-by":"publisher","first-page":"S128","DOI":"10.1016\/s1090-3798(13)70452-5","volume":"17","author":"J Ng","year":"2013","unstructured":"Ng J, Tuschl K, Csanyi B, Kinali M, Devlin A, Carr LJ, Cleary M et al (2013) TH-negative infantile-onset severe dopamine deficiency syndrome. Eur J Paediatr Neurol 17:S128. https:\/\/doi.org\/10.1016\/s1090-3798(13)70452-5","journal-title":"Eur J Paediatr Neurol"},{"issue":"3","key":"652_CR24","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.mito.2008.05.001","volume":"8","author":"A Garcia-Cazorla","year":"2008","unstructured":"Garcia-Cazorla A, Duarte S, Serrano M, Nascimento A (2008) Mitochondrial diseases mimicking neurotransmitter defects. Mitochondrion 8(3):273\u2013278","journal-title":"Mitochondrion"},{"issue":"2","key":"652_CR25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1017\/cjn.2017.271","volume":"45","author":"CDM Van Karnebeek","year":"2018","unstructured":"Van Karnebeek CDM, Dunbar M, Egri C, Sayson B, Milea J, Stockler-Ipsiroglu S, Huh L, Connolly MB, Horvath GA (2018) Secondary abnormal csf neurotransmitter metabolite profiles in a pediatric tertiary care centre. Can J Neurol Sci 45(2):206\u2013213. https:\/\/doi.org\/10.1017\/cjn.2017.271","journal-title":"Can J Neurol Sci"},{"key":"652_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/C2009-0-00066-X","volume-title":"Basic neurochemistry: principles of molecular, cellular, and medical neurobiology","author":"ST Brady","year":"2012","unstructured":"Brady ST, Albers RW, Siegel GJ, Price DL (2012) Basic neurochemistry: principles of molecular, cellular, and medical neurobiology, 8th edn. Academic Press, Amsterdam. https:\/\/doi.org\/10.1016\/C2009-0-00066-X","edition":"8"},{"key":"652_CR27","unstructured":"Bevensee MO (2014) Current topics in membranes. Exchangers. Vol. 73. Academic Press"},{"issue":"1","key":"652_CR28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/cphy.c130021","volume":"4","author":"OH Shin","year":"2014","unstructured":"Shin OH (2014) Exocytosis and synaptic vesicle function. Compr Physiol 4(1):149\u2013175. https:\/\/doi.org\/10.1002\/cphy.c130021","journal-title":"Compr Physiol"},{"issue":"9","key":"652_CR29","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1093\/cercor\/bhu081","volume":"25","author":"M Wolf","year":"2015","unstructured":"Wolf M, Zimmermann AM, G\u00f6rlich A, Gurniak C, Sassoe-Pognetto M, Friauf E, Witke W, Rust M (2015) ADF\/cofilin controls synaptic actin dynamics and regulates synaptic vesicle mobilization and exocytosis. Cereb Cortex 25(9):2863\u20132875","journal-title":"Cereb Cortex"},{"issue":"1","key":"652_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2010.12.017","volume":"508","author":"SC Daubner","year":"2011","unstructured":"Daubner SC, Le T, Wang S (2011) Tyrosine hydroxylase and regulation of dopamine synthesis. Arch Biochem Biophys 508(1):1\u201312","journal-title":"Arch Biochem Biophys"},{"key":"652_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2007.01422.x","author":"T Joensuu","year":"2008","unstructured":"Joensuu T, Lehesjoki AE, Kopra O (2008) Molecular background of EPM1 - Unverricht-Lundborg Disease. Epilepsia. https:\/\/doi.org\/10.1111\/j.1528-1167.2007.01422.x","journal-title":"Epilepsia"},{"issue":"10","key":"652_CR32","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1111\/j.1528-1167.2006.00638.x","volume":"47","author":"A Vaarmann","year":"2006","unstructured":"Vaarmann A, Kaasik A, Zharkovsky A (2006) Altered tryptophan metabolism in the brain of cystatin b-deficient mice: a model system for progressive myoclonus epilepsy. Epilepsia 47(10):1650\u20131654. https:\/\/doi.org\/10.1111\/j.1528-1167.2006.00638.x","journal-title":"Epilepsia"},{"issue":"5","key":"652_CR33","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.parkreldis.2008.08.002","volume":"15","author":"A Puschmann","year":"2009","unstructured":"Puschmann A, Wszolek ZK, Farrer M et al (2009) Alpha-synuclein multiplications with Parkinsonism, dementia or progressive myoclonus? Parkinsonism Relat Disord 15(5):390\u2013392","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"652_CR34","first-page":"633","volume":"28","author":"CS Gondi","year":"2006","unstructured":"Gondi CS, Kandhukuri N, Kondraganti S, Gujrati M, Olivero WC, Dinh DH, Rao JS (2006) Down-regulation of UPAR and cathepsin B retards cofilin dephosphorylation. Int J Oncol 28(3):633\u201339","journal-title":"Int J Oncol"},{"key":"652_CR35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jns.2017.04.047","volume":"378","author":"G Horvath","year":"2017","unstructured":"Horvath G, Meisner L, Selby K, Stowe R, Carleton B (2017) Improved strength on 5-hydroxytryptophan and carbidopa in spinal cord atrophy. J Neurol Sci 378:59\u201362. https:\/\/doi.org\/10.1016\/j.jns.2017.04.047","journal-title":"J Neurol Sci"},{"key":"652_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ymgmr.2016.09.006","volume":"9","author":"T Opladen","year":"2016","unstructured":"Opladen T, Cortes-Saladelafont E, Mastrangelo M, Horvath G, Pons R, Lopez-Laso E, Fernandez-Ramos J, Honzik T, Pearson T, Fredman J, Scholl-Burgi S, Wassenburg T, Jung-Klawitter S, Kuseyri O, Jeltsch K, Kurian M, Garcia-Cazorla A (2016) The international working group on neurotransmitter related disorders (iNTD): a worldwide research project focused on primary and secondary neurotransmitter disorders. Mol Genet Metab Rep 9:61\u201366. https:\/\/doi.org\/10.1016\/j.ymgmr.2016.09.006","journal-title":"Mol Genet Metab Rep"}],"container-title":["neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-021-00652-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10048-021-00652-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-021-00652-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T04:06:15Z","timestamp":1631073975000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10048-021-00652-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,2]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["652"],"URL":"https:\/\/doi.org\/10.1007\/s10048-021-00652-7","relation":{},"ISSN":["1364-6745","1364-6753"],"issn-type":[{"value":"1364-6745","type":"print"},{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,2]]},"assertion":[{"value":"14 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}